Chemical Properties of Acridan, 2-chloro-9-(3-dimethylaminopropyl)-10-ethyl-, phosphate (1 to 1),dihydrate

Acridan, 2-chloro-9-(3-dimethylaminopropyl)-10-ethyl-, phosphate (1 to 1),dihydrate

InChI
InChI=1S/C20H25ClN2.H3O4P.2H2O/c1-4-23-19-10-6-5-8-17(19)16(9-7-13-22(2)3)18-14-15(21)11-12-20(18)23;1-5(2,3)4;;/h5-6,8,10-12,14,16H,4,7,9,13H2,1-3H3;(H3,1,2,3,4);2*1H2
InChI Key
LTSMMCBWPWUMFP-UHFFFAOYSA-N
Formula
C20H32ClN2O6P
SMILES
CCN1c2ccccc2C(CCCN(C)C)c2cc(Cl)ccc21.O.O.O=P(O)(O)O
Molecular Weight1
462.91
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Cheméo can also estimate Normal Boiling Point Temperature, Normal melting (fusion) point, Critical Temperature, Critical Pressure, Critical Volume, Enthalpy of formation at standard conditions, Enthalpy of vaporization at standard conditions, Standard Gibbs free energy of formation, Acentric Factor, Ionization energy, Log10 of Water solubility in mol/l for this compound, but they fall outside the models' validated range, so they are not shown here. Open the prediction tool to compute them on demand.

Similar Compounds

Tazettine. Dehydrocytisine. cis-1,2-Indanediol, ferrocenylboronate. Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3«alpha»,14«alpha»,16«alpha»)-. BUPRENORPHINE. 3-propionyl-morphine. Neopine. Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). 3,4-Dichloro-alpha-methoxybenzylpenicillin, potassium salt. Guanosine, N-trimethylsilyl-, 2',3',5'-tris(trimethylsilyl) ether. Normorphine, N-trimethylsilyl-, bis(trimethylsilyl) ether. Norcodeine. Brucine. ERGOTAMINE. Deserpidine.

Find more compounds similar to Acridan, 2-chloro-9-(3-dimethylaminopropyl)-10-ethyl-, phosphate (1 to 1),dihydrate.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.